Indaptus Therapeutics Stock (NASDAQ: INDP) stock price, news, charts, stock research, profile.
You can purchase shares of Indaptus Therapeutics (NASDAQ:INDP) through any online brokerage.
Other companies in Indaptus Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN), T2 Biosystems (NASDAQ:TTOO) and Can Fite Biofarma (AMEX:CANF).
Indaptus Therapeutics has a consensus price target of $8.50.
The stock price for Indaptus Therapeutics (NASDAQ: INDP) is $1.028 last updated November 20, 2024 at 4:28 PM EST.
There are no upcoming dividends for Indaptus Therapeutics.
Indaptus Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Indaptus Therapeutics.
Indaptus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.